Cellectar Biosciences, Inc. (CLRB) vs Estrella Immunopharma, Inc. (ESLA)
Cellectar Biosciences, Inc. and Estrella Immunopharma, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and Estrella Immunopharma, Inc. are of similar size ($20.5M and $19.6M). Across the 7 metrics below, Estrella Immunopharma, Inc. leads on 4 and Cellectar Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | CLRB | ESLA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (125.99%) | 148.05% | (57.72%) |
| Return on assets | (88.70%) | (416.74%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack